Annual Total Liabilities
$122.96 M
-$294.85 M-70.57%
December 31, 2023
Summary
- As of February 28, 2025, DNLI annual total liabilities is $122.96 million, with the most recent change of -$294.85 million (-70.57%) on December 31, 2023.
- During the last 3 years, DNLI annual total liabilities has fallen by -$330.79 million (-72.90%).
- DNLI annual total liabilities is now -72.90% below its all-time high of $453.75 million, reached on December 31, 2020.
Performance
DNLI Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$135.52 M
+$20.00 M+17.32%
September 30, 2024
Summary
- As of February 28, 2025, DNLI quarterly total liabilities is $135.52 million, with the most recent change of +$20.00 million (+17.32%) on September 30, 2024.
- Over the past year, DNLI quarterly total liabilities has increased by +$20.00 million (+17.32%).
- DNLI quarterly total liabilities is now -70.13% below its all-time high of $453.75 million, reached on December 31, 2020.
Performance
DNLI Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
DNLI Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -70.6% | +17.3% |
| 3 y3 years | -72.9% | -67.6% |
| 5 y5 years | +6.8% | -67.6% |
DNLI Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -72.2% | at low | -69.4% | +17.3% |
| 5 y | 5-year | -72.9% | at low | -70.1% | +17.3% |
| alltime | all time | -72.9% | +487.6% | -70.1% | +689.2% |
Denali Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $135.52 M(+17.3%) |
| Jun 2024 | - | $115.51 M(-8.0%) |
| Mar 2024 | - | $125.62 M(+2.2%) |
| Dec 2023 | $122.96 M(-70.6%) | $122.96 M(+3.8%) |
| Sep 2023 | - | $118.45 M(-0.4%) |
| Jun 2023 | - | $118.91 M(-73.1%) |
| Mar 2023 | - | $442.64 M(+5.9%) |
| Dec 2022 | $417.81 M(-5.4%) | $417.81 M(+0.4%) |
| Sep 2022 | - | $416.30 M(+2.0%) |
| Jun 2022 | - | $408.01 M(+1.3%) |
| Mar 2022 | - | $402.93 M(-8.8%) |
| Dec 2021 | $441.87 M(-2.6%) | $441.87 M(+1.0%) |
| Sep 2021 | - | $437.69 M(+0.1%) |
| Jun 2021 | - | $437.11 M(-1.2%) |
| Mar 2021 | - | $442.50 M(-2.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2020 | $453.75 M(+186.6%) | $453.75 M(+141.7%) |
| Sep 2020 | - | $187.76 M(+29.3%) |
| Jun 2020 | - | $145.17 M(-3.6%) |
| Mar 2020 | - | $150.55 M(-4.9%) |
| Dec 2019 | $158.34 M(+37.5%) | $158.34 M(-3.9%) |
| Sep 2019 | - | $164.78 M(+1.4%) |
| Jun 2019 | - | $162.43 M(+1.6%) |
| Mar 2019 | - | $159.95 M(+38.9%) |
| Dec 2018 | $115.14 M(+450.2%) | $115.14 M(+38.2%) |
| Sep 2018 | - | $83.30 M(+1.9%) |
| Jun 2018 | - | $81.78 M(+9.2%) |
| Mar 2018 | - | $74.92 M(+258.1%) |
| Dec 2017 | $20.93 M(-94.3%) | $20.93 M(+21.9%) |
| Sep 2017 | - | $17.17 M(-95.3%) |
| Dec 2016 | $365.22 M(+598.1%) | $365.22 M |
| Dec 2015 | $52.32 M | - |
FAQ
- What is Denali Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Denali Therapeutics?
- What is Denali Therapeutics annual total liabilities year-on-year change?
- What is Denali Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Denali Therapeutics?
- What is Denali Therapeutics quarterly total liabilities year-on-year change?
What is Denali Therapeutics annual total liabilities?
The current annual total liabilities of DNLI is $122.96 M
What is the all time high annual total liabilities for Denali Therapeutics?
Denali Therapeutics all-time high annual total liabilities is $453.75 M
What is Denali Therapeutics annual total liabilities year-on-year change?
Over the past year, DNLI annual total liabilities has changed by -$294.85 M (-70.57%)
What is Denali Therapeutics quarterly total liabilities?
The current quarterly total liabilities of DNLI is $135.52 M
What is the all time high quarterly total liabilities for Denali Therapeutics?
Denali Therapeutics all-time high quarterly total liabilities is $453.75 M
What is Denali Therapeutics quarterly total liabilities year-on-year change?
Over the past year, DNLI quarterly total liabilities has changed by +$20.00 M (+17.32%)